Posts

Is inflammation the next therapeutic target in intracerebral hemorrhage?

Highlights of the European Stroke Journal: Keep Calm and Carry On!

Stroke prevention – we can do better!

ESO Blog and YSPR Corner 2019: Keep Calm and Carry On

By Linxin Li and Diana Aguiar de Sousa on behalf of the YSPR…

ESOC 2018- Stroke Prevention and Epidemiology

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="4_4"][et_pb_button…

ESOC Session Highlight – Prevention Non Trials

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="4_4"][et_pb_button…

Who Watches the Watchmen? – LAA closure for stroke protection

As primary source of thromboembolism in atrial fibrillation, the left atrial appendage (LAA) qualifies as a target for mechanical interventions for stroke prevention.1 In particular for patients at high bleeding risk, local therapies, which exclude the LAA from the systemic circulation, offer a treatment alternative to oral anticoagulation for cardioembolic stroke prevention.